ImmunoBiome Inc.

Private

PohangHealthcare & Life Scienceshttps://www.immunobiome.co.kr/

Last Round

Series B

Jan 1, 2022

Total Funding Raised

$23.81M

Company Overview

ImmunoBiome Inc. is a biotechnology company that develops microbiome-targeted therapeutics and live biotherapeutic products (LBPs) for incurable diseases such as cancer, autoimmune disorders, and autism spectrum disorders.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Infrastructure

Keywords

microbiome therapeuticslive biotherapeutic productsLBPgut microbiomedrug discoveryautoimmune disease treatmentmicrobiome drugbioinformaticsAI drug discoveryprecision medicinebiotech R&Dgut bacteriamicrobiome diagnosticstherapeutic pipelinepreclinical development

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

ImmunoBiome Inc. Comps

Public and private peers based on sector, stage, and business model.

ImmunoBiome Inc. comps — public and private peers by sector, stage, and business model
Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

ImmunoBiome Inc. Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
Series B	Jan 1, 2022
Series A	Sep 1, 2020
Pre Seed	Dec 1, 2019
Seed	Jul 1, 2019

View all Funding Rounds

ImmunoBiome Inc. Investors

Notable investors and investment history

ImmunoBiome Inc. investors
Investor	Rounds
Korea Investment & Securities	Series B
Korea Investment Partners	Series B, Series A
Company K Partners	Series B
Brain Asset Management Co.,Ltd.	Series B
Union Investment Partners	Series B
KTB Investment Group	Series B

View all Investors

ImmunoBiome Inc. Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

ImmunoBiome Inc. Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about ImmunoBiome Inc.'s valuation, stock price, and market status.

Firmographic Details

HeadquartersPohang

Employee Range21

Year Founded2019

Last FundingJan 1, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.